Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2026-01-06 @ 6:04 AM
Study NCT ID:
NCT00306592
Status:
COMPLETED
Last Update Posted:
2017-03-21
First Post:
2006-01-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Natalizumab Re-Initiation of Dosing
Sponsor:
Biogen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
101-MS-322
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |